Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19

(2020) Reinhold Kreutz et al.   CARDIOVASCULAR RESEARCH

Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors

(2020) Xian Zhou et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019

(2020) Sara Tedeschi et al.   CLINICAL INFECTIOUS DISEASES

Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study

(2020) Sun-Young Jung et al.   CLINICAL INFECTIOUS DISEASES

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

(2020) Bo Li et al.   Clinical Research in Cardiology

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

(2020) Yuchen Chen et al.   DIABETES CARE

Coronaviruses and the cardiovascular system: acute and long-term implications

(2020) Tian-Yuan Xiong et al.   EUROPEAN HEART JOURNAL

Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19

(2020) Nian-Di Tan et al.   GASTROENTEROLOGY

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome

(2020) Jianhua Hu et al.   JOURNAL OF INFECTION

Ramipril in High Risk Patients with COVID-19

(2020) Ignacio J. Amat-Santos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

(2020) Francisco J de Abajo et al.   LANCET

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

(2020) Neil Mehta et al.   JAMA Cardiology

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Tao Guo et al.   JAMA Cardiology

Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China

(2020) Juyi Li et al.   JAMA Cardiology

Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19

(2020) David J. Bae et al.   AMERICAN JOURNAL OF CARDIOLOGY

Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

(2020) Murat Selçuk et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

(2020) Chao Gao et al.   EUROPEAN HEART JOURNAL

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

(2020) Julia Hippisley-Cox et al.   HEART

Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients

(2020) Priyank Shah et al.   JOURNAL OF HYPERTENSION

Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes

(2020) Katherine W Lam et al.   JOURNAL OF INFECTIOUS DISEASES

Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study

(2020) Jong-moon Hwang et al.   NEUROLOGICAL SCIENCES

Could anti‐hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID‐19 infection? Data from centers of southern Italy

(2020) Celestino Sardu et al.   Journal of the American Heart Association

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

(2020) Jiuyang Xu et al.   Frontiers of Medicine

Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients

(2020) Ranu Baral et al.   Current Atherosclerosis Reports

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

(2020) Gianluca Trifirò et al.   DRUG SAFETY

Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

(2020) Yasushi Matsuzawa et al.   HYPERTENSION RESEARCH

Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study

(2020) Selcuk Gormez et al.   JOURNAL OF HUMAN HYPERTENSION

Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study

(2020) Khurram Shahzad Khan et al.   SCOTTISH MEDICAL JOURNAL

Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients

(2020) Chen Chen et al.   Journal of the American Heart Association

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Closing the Gap between Methodologists and End-Users:Ras a Computational Back-End

(2015) Byron C. Wallace et al.   Journal of Statistical Software

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

(2014) M. Furuhashi et al.   AMERICAN JOURNAL OF HYPERTENSION